Freeze-Dried Platelet Product for the Treatment of Trauma-Associated Blood Loss in Canines
Archived on March 17, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:00 PM EST
- Posted
- January 30, 2026
- Notice type
- Sources Sought
- Set-aside
- No Set aside used
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- DEFENSE HEALTH AGENCY
- Place of performance
- Maryland, 21702
- Last updated
- Nov 3, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- HT9427-26-RFI-703
- Notice ID
- aeb0fd155b814fcb977f4b55e0c170aa
Description
The OPMED is conducting market research to identify technologies that meet requirements for the development of a freeze-dried platelet product for the treatment of trauma-associated blood loss in canines. This market research may also assist with the further development and/or refinement of the requirements.
Military Working Dogs (MWDs) play a critical role in protecting human lives and supporting military objectives in the operational environment. MWDs work in close conjunction with their handlers and Service Members and are exposed to the same combat trauma threats and similar non-battle injury risks, and thus canine blood or blood components are indicated for appropriate treatment.
The OPMED has a requirement to develop, deliver, and field safe and effective Canine Blood Products (CBP) for the treatment of traumatic hemorrhage. The CBP program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products and evacuation may be limited.
This RFI seeks responses to the canine freeze-dried platelet component of this FoS only.
North American Industry Classification System (NAICS) Code: Unknown.
RFI Attachments: The following documents are attached to the RFI: A02-RFI for Freeze Dried Platelet Canine
Attachment 1: Technology Readiness Levels (TRLs) (Reference Only)
Attachment 2: Company & Product Information
Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on March 2, 2026, via e-mail to:
Katherine Ramsburg via email at: katherine.j.ramsburgciv@health.mil
Email Subject/title: "RFI response for HT9427-26-RF
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (3)
- Download
A02 RFI for FREEZE-DRIED PLATELET CANINE_wgh.pdf
330 KBAdded in Sources Sought version 3Posted - Download
A02 Attachment 2 - Company Product Information.docx
15 KBAdded in Sources Sought version 3Posted - Download
A02 Attachment 1 - Technology Readiness Level (TRL) (Reference only).pdf
99 KBAdded in Sources Sought version 3Posted
Lifecycle
- 3Version 3Sources SoughtArchivedCurrent
Freeze-Dried Platelet Product for the Treatment of Trauma-Associated Blood Loss in Canines
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
HT9427-26-RFI-703
Archive Date
Mar 17, 2026
Office Address
FORT DETRICK, MD, 21702